Premium
Hyaluronan‐binding peptide can inhibit tumor growth by interacting with Bcl‐2
Author(s) -
Liu Ninfei,
Xu XueMing,
Chen Jinguo,
Wang Luping,
Yang Shanmin,
Underhill Charles B.,
Zhang Lurong
Publication year - 2003
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.11636
Subject(s) - angiogenesis , apoptosis , peptide , microbiology and biotechnology , biology , mitochondrion , cytochrome c , chorioallantoic membrane , biochemistry , embryo , cancer research
Previous studies have indicated that proteins that bind hyaluronan can also inhibit the growth of tumor cells. To determine if synthetic peptides also possessed these properties, we tested a series of polypeptides containing structural motifs from different proteins for their ability to bind [ 3 H]hyaluronan, and identified one compound termed P4 that had a particularly strong interaction. Further studies revealed that P4 also inhibited the growth of tumor cells in tissue culture as well as on the chorioallantoic membranes of chicken embryos. In addition, expression vectors for P4 caused tumor cells to grow slower in nude mice and reduced their vascularization. The P4 peptide also inhibited VEGF‐induced angiogenesis in the chorioallantoic membranes of chicken embryos. Studies on cultured cells indicated that P4 induced apoptosis, which was blocked by a pan‐caspase inhibitor. Confocal microscopy revealed that shortly after its uptake, P4 became associated with mitochondria. Immunoprecipitation indicated that P4 could bind to Bcl‐2 and Bcl‐x L , which are associated with mitochondria and regulate apoptosis. This was also supported by the fact that P4 induced the release of cytochrome c from preparations of mitochondria. Taken together, these results suggest that P4 binds to Bcl‐2 and related proteins and this activates the apoptotic cascade. © 2003 Wiley‐Liss, Inc.